Top Page
EPX
(Sydney:EPX)
EPX (EPX) vs. iShares MSCI Australia ETF (EWA)
EPX Business Overview & Revenue Model
EPX Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.27M | 15.27M | 13.03M | 10.63M | 7.09M | 6.08M |
| Gross Profit | 3.31M | 3.31M | 12.11M | -2.72M | 6.28M | 5.87M |
| EBITDA | -3.09M | -3.09M | -1.97M | -4.84M | -7.11M | -11.67M |
| Net Income | -5.75M | -5.75M | -4.84M | -6.75M | -8.40M | -12.16M |
Balance Sheet | ||||||
| Total Assets | 12.85M | 12.85M | 14.92M | 15.64M | 14.64M | 14.27M |
| Cash, Cash Equivalents and Short-Term Investments | 1.29M | 1.29M | 1.40M | 1.24M | 4.22M | 5.30M |
| Total Debt | 1.21M | 1.21M | 1.54M | 1.94M | 1.24M | 1.17M |
| Total Liabilities | 12.32M | 12.32M | 9.98M | 8.71M | 6.45M | 6.16M |
| Stockholders Equity | 523.08K | 523.08K | 4.93M | 6.93M | 8.18M | 8.11M |
Cash Flow | ||||||
| Free Cash Flow | -98.64K | -98.64K | -1.66M | -7.11M | -8.33M | -5.19M |
| Operating Cash Flow | 1.42M | 1.42M | -206.11K | -4.47M | -6.12M | -3.43M |
| Investing Cash Flow | -1.64M | -1.64M | -1.46M | -2.64M | -2.21M | -1.76M |
| Financing Cash Flow | 105.09K | 105.09K | 1.86M | 4.01M | 7.25M | 10.22M |
EPX Technical Analysis
EPX Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$45.59M | -1.59 | -64.51% | 4.95% | -38.38% | -275.50% | |
46 Neutral | AU$9.61M | -2.63 | ― | ― | 13.07% | 68.60% | |
42 Neutral | AU$22.83M | -1.46 | -54.62% | ― | -22.47% | 39.26% | |
42 Neutral | AU$6.92M | -4.44 | -23.31% | ― | 2.15% | -900.00% | |
41 Neutral | ― | -3.93 | -210.85% | ― | 17.19% | 4.50% |
EPX Corporate Events
EPX Limited has announced a change in the director’s interest, specifically involving Paul Oneile. The change involves the acquisition of 1,000,000 performance rights, which were issued following shareholder approval at the Annual General Meeting on November 27, 2025. This adjustment reflects a strategic move within the company’s governance, potentially impacting the company’s future operations and shareholder dynamics.
EPX Limited has announced a change in the director’s interest, specifically regarding Elizabeth Aris, who has acquired 1,000,000 performance rights. This acquisition was made following shareholder approval at the company’s Annual General Meeting on November 27, 2025. The change reflects an increase in the director’s holdings, which could indicate confidence in the company’s future performance and align the director’s interests with those of the shareholders.
EPX Limited announced that all resolutions were passed at their 2025 Annual General Meeting, with decisions made via a poll. The effective date for the securities consolidation is set for November 27, 2025. This development is expected to reinforce EPX’s operational strategies and potentially enhance its market position in the building performance sector.
EPX Limited has reported significant progress in the past financial year, achieving positive cash flow from operations and increasing its statutory recurring revenue by 23% to $15 million. The integration of CODA, a UK company acquired last year, has expanded opportunities in Australia and Europe. The company is focusing on sales, product development, and cash flow management, while seeking further inorganic growth opportunities. With rising energy costs and legislative demands for carbon reduction, EPX is well-positioned to assist property owners in optimizing energy use and reducing carbon footprints.
EPX Limited has announced the issuance of 6,000,000 performance rights under an employee incentive scheme. These securities are unquoted and subject to a restriction on transfer until the restriction period ends. This move is part of EPX’s strategy to incentivize and retain employees, potentially impacting its operational efficiency and aligning employee interests with company performance.
EPX Limited has announced a security consolidation affecting its ordinary fully paid shares, performance rights, and options. This reorganization will commence trading on a deferred settlement basis from December 1, 2025, with a record date of December 2, 2025, and an issue date of December 9, 2025. The consolidation has received the necessary security holder approval, which was confirmed on November 27, 2025. This move is likely aimed at optimizing the company’s capital structure and could impact its market positioning and shareholder value.
EPX Limited has announced its 2025 Annual General Meeting, which will be held virtually on November 27, 2025. The meeting will address several key business items, including the consideration of the company’s financial reports and the adoption of the remuneration report for the financial year ending June 30, 2025. The remuneration report vote is advisory and will not bind the directors or the company. The meeting will also include voting exclusions for certain key management personnel and their related parties.
EPX Limited, a company listed on the Australian Securities Exchange, reported a net increase in its Annual Contract Value (ACV) to $18.0 million for the quarter ending September 2025, despite a $0.4 million reduction due to a court settlement with a nonperforming UAE customer. The company also saw its Annual Recurring Revenue (ARR) rise to $15.7 million, with site numbers growing to 759, indicating steady operational growth and expansion in both the UAE and Australia. The announcement highlights EPX’s strategic wins, including a significant partnership with a leading UAE healthcare organization and new contracts in the Australian property development sector, positioning the company for continued growth in its market.
EPX Limited has released its FY25 annual results presentation, which provides a general overview of the company’s financial status and activities as of September 2025. The presentation emphasizes that the information is for illustrative purposes only and does not constitute an offer or solicitation for investment. It also highlights the speculative and high-risk nature of investing in EPX shares due to the company’s startup status and the inherent risks involved.
EPX Limited has announced a shareholder webinar to present its FY25 financial results, hosted by CEO John Balassis and CFO Patrick Harsas. The webinar will provide insights into the company’s performance and updates, highlighting EPX’s continued impact on energy efficiency in the built environment. This event underscores EPX’s commitment to transparency and engagement with stakeholders, reinforcing its position as a leader in the building performance sector.
EPX Limited has secured a significant seven-year contract valued at over A$5 million with a major UAE healthcare organization to implement its EDGE technology across 10 healthcare facilities. This agreement marks EPX’s continued expansion into the healthcare market, enhancing energy efficiency and reducing CO2 emissions, while positioning the company as a key player in the UAE’s sustainability efforts.